Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database study

Article English OPEN
Bedson, J. ; Chen, Y. ; Hayward, R. A. ; Ashworth, J. ; Walters, K. ; Dunn, K. M. ; Jordan, K. P. (2016)
  • Journal: Pain, volume 157, issue 7, pages 1,525-1,531 (issn: 0304-3959, eissn: 1872-6623)
  • Related identifiers: doi: 10.1097/j.pain.0000000000000557, pmc: PMC4912234
  • Subject: Analgesic, Opioid, Trends, Prescriptions, Musculoskeletal pain, Long-term care | Musculoskeletal pain | Analgesic | Opioid | Long-term care | Research Paper | Prescriptions | Trends | R1

Abstract Long-term opioids may benefit patients with chronic pain but have also been linked to harmful outcomes. In the United Kingdom, the predominant source of opioids is primary care prescription. The objective was to examine changes in the incidence, length, and opioid potency of long-term prescribing episodes for musculoskeletal conditions in UK primary care (2002-2013). This was an observational database study (Clinical Practice Research Datalink, 190 practices). Participants (≥18 years) were prescribed an opioid for a musculoskeletal condition (no opioid prescribed in previous 6 months), and issued ≥2 opioid prescriptions within 90 days (long-term episode). Opioids were divided into short- and long-acting noncontrolled and controlled drugs. Annual incidence of long-term opioid episodes was determined, and for those still in a long-term episode, the percentage of patients prescribed each type 1 to 2 years, and >2 years after initiation. Annual denominator population varied from 1.25 to 1.38 m. A total of 76,416 patients started 1 long-term episode. Annual long-term episode incidence increased (2002-2009) by 38% (42.4-58.3 per 10,000 person-years), remaining stable to 2011, then decreasing slightly to 55.8/10,000 (2013). Patients prescribed long-acting controlled opioids within the first 90 days of long-term use increased from 2002 to 2013 (2.3%-9.9%). In those still in a long-term opioid episode (>2 years), long-acting controlled opioid prescribing increased from 3.5% to 22.6%. This study has uniquely shown an increase in prescribing long-term opioids to 2009, gradually decreasing from 2011 in the United Kingdom. The trend was towards increased prescribing of controlled long-acting opioids and earlier use. Further research into the risks and benefits of opioids is required.
  • References (46)
    46 references, page 1 of 5

    [1] Bedson J, Belcher J, Martino OI, Ndlovu M, Rathod T, Walters K, Dunn KM, Jordan KP. The effectiveness of national guidance in changing analgesic prescribing in primary care from 2002 to 2009: an observational database study. Eur J Pain 2013;17:434-43.

    [2] BNF. British national formulary. London: BMJ Group, 2014.

    [3] Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009;18:1166-75.

    [4] Care Quality Commission. The safer management of controlled drugs, Annual report 2012. 2013. Available at: default/files/documents/cdar_2012.pdf. Accessed September 19, 2015.

    [5] Chevalier P, Smulders M, Chavoshi S, Sostek M, LoCasale R. A description of clinical characteristics and treatment patterns observed within prescribed opioid users in Germany and the UK. Pain Manag 2014; 4:267-76.

    [6] Department of Health. Controlled drugs (supervision of management and use) regulations 2013. 2013. Available at: government/uploads/system/uploads/attachment_data/file/214915/ 15-02-2013-controlled-drugs-regulation-information.pdf. Accessed September 19, 2015.

    [7] Department of Health (England) and the Devolved Administrations. Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive, 2007.

    [8] Dowd A. Some PCTs recommend GPs limit prescriptions to 28 days. BMJ 2011;342:d2410.

    [9] Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose. Ann Intern Med 2010; 152:85-92.

    [10] Edwards JJ, Jordan KP, Peat G, Bedson J, Croft PR, Hay EM, Dziedzic KS. Quality of care for OA: the effect of a point-of-care consultation recording template. Oxford: Anonymous Rheumatology, 2014.

  • Metrics
    No metrics available
Share - Bookmark